Role of Sarcoendoplasmic Reticulum Calcium ATPase Pump in Airway Smooth Muscle Function
Author: Oluwaseun O Ojo
Publisher:
Published: 2011
Total Pages: 398
ISBN-13:
DOWNLOAD EBOOKAsthma is a chronic inflammatory disease of the airway with hallmarks of remodelling, inflammation, hyper-responsiveness and bronchonstricition. All of these implicate airway smooth muscle (ASM) and alterations in ASM calcium homeostasis. We have found that the latter is mediated through diminished SERCA-2 expression, which correlates with disease severity. I investigated the role of SERCA-2 knock-down on ASM function using siRNA in ASM cells from healthy volunteers, and studied responses implicated in airway remodelling and inflammation. Calcium transients in healthy ASM following SERCA-2 knock-down resembled those from asthmatic ASM. Likewise, ASM proliferation in response to FBS and PDGF-[beta][beta], estimated using 3H-thymidine incorporation, was increased following SERCA-2 knock-down, similar to untreated ASM cells from asthmatics. SERCA-2 knock-down in both healthy and asthmatic ASM cells also elicited an increase in eotaxin-1 production in both untreated and IL-13 treated ASM cells. Collectively these data strongly suggest a key role for reduced SERCA-2 expression in the altered function and phenotype of ASM from asthmatics. To identify the cause of the diminished expression of SERCA-2 in asthma, I investigated the effect of asthma-associated mediators (cytokines and therapy) on SERCA-2 expression in healthy ASM cells, and observed decreased SERCA-2 expression following treatment with IL-13 and transforming growth factor- [beta](TGF[beta]); the later caused a reduction in expression that was sustained up to 14 days after removal of TGF[beta] following an initial 24 and 72 hrs exposure. Similarly, the long acting [beta]2 adrenoreceptor agonist formoterol also caused reduced expression of SERCA-2, and this was prevented by [beta]2 antagonists (ICI-118551) and inhibition of ERK signalling.